Novartis AG on Friday won U.S. approval for its experimental sickle cell disease drug, Adakveo, making it the first of several proposed new therapies designed to offer lasting relief for patients with the debilitating blood disease to get U.S. reg...
![]()
By Reuters from NYT Business Day https://ift.tt/2pmp62O
By Reuters from NYT Business Day https://ift.tt/2pmp62O
Novartis Sickle-Cell Drug Gets U.S. FDA Approval
![Novartis Sickle-Cell Drug Gets U.S. FDA Approval]()
Reviewed by Unknown
on
November 15, 2019
Rating:
No comments: